全文获取类型
收费全文 | 4075517篇 |
免费 | 353072篇 |
国内免费 | 37984篇 |
专业分类
耳鼻咽喉 | 55321篇 |
儿科学 | 121275篇 |
妇产科学 | 103158篇 |
基础医学 | 624205篇 |
口腔科学 | 106625篇 |
临床医学 | 386507篇 |
内科学 | 730028篇 |
皮肤病学 | 103428篇 |
神经病学 | 340364篇 |
特种医学 | 157871篇 |
外国民族医学 | 765篇 |
外科学 | 619727篇 |
综合类 | 159925篇 |
现状与发展 | 168篇 |
一般理论 | 2391篇 |
预防医学 | 323250篇 |
眼科学 | 97005篇 |
药学 | 291773篇 |
356篇 | |
中国医学 | 28545篇 |
肿瘤学 | 213886篇 |
出版年
2022年 | 34487篇 |
2021年 | 70811篇 |
2020年 | 48280篇 |
2019年 | 68254篇 |
2018年 | 84575篇 |
2017年 | 66346篇 |
2016年 | 71760篇 |
2015年 | 89881篇 |
2014年 | 129720篇 |
2013年 | 192055篇 |
2012年 | 126851篇 |
2011年 | 130840篇 |
2010年 | 137148篇 |
2009年 | 138850篇 |
2008年 | 109078篇 |
2007年 | 112809篇 |
2006年 | 123396篇 |
2005年 | 117389篇 |
2004年 | 112168篇 |
2003年 | 101409篇 |
2002年 | 89600篇 |
2001年 | 143703篇 |
2000年 | 138608篇 |
1999年 | 131562篇 |
1998年 | 74149篇 |
1997年 | 70707篇 |
1996年 | 67238篇 |
1995年 | 62162篇 |
1994年 | 55305篇 |
1993年 | 50915篇 |
1992年 | 88582篇 |
1991年 | 83241篇 |
1990年 | 78349篇 |
1989年 | 77025篇 |
1988年 | 70625篇 |
1987年 | 68700篇 |
1986年 | 64415篇 |
1985年 | 63429篇 |
1984年 | 55288篇 |
1983年 | 49624篇 |
1982年 | 44021篇 |
1981年 | 41041篇 |
1980年 | 38582篇 |
1979年 | 44823篇 |
1978年 | 38211篇 |
1977年 | 34685篇 |
1976年 | 31403篇 |
1975年 | 30148篇 |
1974年 | 31615篇 |
1973年 | 30435篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
992.
Thomas W. McDade Alexander V. Georgiev Christopher W. Kuzawa 《Evolution, Medicine, and Public Health》2016,2016(1):1-16
Immune defenses provide resistance against infectious disease that is critical to survival. But immune defenses are costly, and limited resources allocated to immunity are not available for other physiological or developmental processes. We propose a framework for explaining variation in patterns of investment in two important subsystems of anti-pathogen defense: innate (non-specific) and acquired (specific) immunity. The developmental costs of acquired immunity are high, but the costs of maintenance and activation are relatively low. Innate immunity imposes lower upfront developmental costs, but higher operating costs. Innate defenses are mobilized quickly and are effective against novel pathogens. Acquired responses are less effective against novel exposures, but more effective against secondary exposures due to immunological memory. Based on their distinct profiles of costs and effectiveness, we propose that the balance of investment in innate versus acquired immunity is variable, and that this balance is optimized in response to local ecological conditions early in development. Nutritional abundance, high pathogen exposure and low signals of extrinsic mortality risk during sensitive periods of immune development should all favor relatively higher levels of investment in acquired immunity. Undernutrition, low pathogen exposure, and high mortality risk should favor innate immune defenses. The hypothesis provides a framework for organizing prior empirical research on the impact of developmental environments on innate and acquired immunity, and suggests promising directions for future research in human ecological immunology. 相似文献
993.
994.
Micro‐evolution of the hepatitis B virus genome in hepatitis B e‐antigen‐positive carriers: Comparison of genotypes B and C at various immune stages
下载免费PDF全文
![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
995.
996.
Walid K. Abu Saleh Phillip Mason Odeaa Al Jabbari Hany Samir Brian A. Bruckner 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2015,42(6):569-571
The Impella 5.0, a percutaneously inserted left ventricular assist device, has been used to support patients who have severe heart failure or who are undergoing high-risk percutaneous coronary intervention. We report our surgical placement of the Impella 5.0, through a graft sewn to the aorta, to unload the left ventricle of a 59-year-old man who was undergoing venoarterial extracorporeal membrane oxygenation for postcardiotomy shock. The patient underwent successful placement of a long-term left ventricular assist device before his discharge from the hospital. The versatility of the Impella 5.0 is exemplified in this patient who was successfully bridged to long-term support. 相似文献
997.
998.
苏州科技城医院坐落于苏州高新区太湖之滨,由苏州高新区政府投资新建,是一所集医疗、科研、康复、预防于一体的三级综合性公立医院。医院占地面积140亩,总建筑面积180000m~2,总投资额16亿,设计床位1200张。医院于2013年9月29日奠基,2014年12月28日主体封顶,2016年4月正式投入使用,比预定日期提前了将近1年! 相似文献
999.
1000.
Rene S. Hendriksen Pimlapas Leekitcharoenphon Matthew Mikoleit Jacob Dyring Jensen Rolf Sommer Kaas Louise Roer Heena B. Joshi Srirat Pornruangmong Chaiwat Pulsrikarn Gladys D. Gonzalez-Aviles E. Ascelijn Reuland Nashwan Al Naiemi Astrid Louise Wester Frank M. Aarestrup Henrik Hasman 《Journal of clinical microbiology》2015,53(2):677-680
One unreported case of extended-spectrum-beta-lactamase (ESBL)-producing Salmonella enterica serovar Typhi was identified, whole-genome sequence typed, among other analyses, and compared to other available genomes of S. Typhi. The reported strain was similar to a previously published strain harboring blaSHV-12 from the Philippines and likely part of an undetected outbreak, the first of ESBL-producing S. Typhi. 相似文献